Genetic structure could hold some answers to the vexed issue of cancer. A reference set of genetic variants, specific to India’s diverse ethnic groups, can improve disease modelling and treatment.
Related Posts
Sun Pharma’s new drug to take on Pfizer, Eli Lilly is having a bad hair day.
Synopsis Last year, Sun Pharma infused over INR4,688 crore to buy US-based Concert Pharma. That deal gave it rights to…
Data-integrity woes have come back to haunt Indian pharma. How can it deal with the USFDA’s glare?
Regulatory lapses have been hurting the industry since long. In several instances earlier, such issues had eroded the financials of…
Chronic Lyme and other pathogens: Tackling long-haul diseases.
As long-haul infections continue to surge, and climate change pushes ticks into new habitats, finding out the causes of these…
